An unfortunate consequence of Ido1 induction is elevated production and release of downstream neuroactive Kyn metabolites (QuinA and KynA) that mediate depression-like, anxiogenic, and adverse cognitive behaviors (49). The gene discussed is IDO1; the disease is depressive symptom measurement.